The exploitation of Toll-like receptor 3 signaling in cancer therapy.

Glavan, Tanja Matijevic

The exploitation of Toll-like receptor 3 signaling in cancer therapy. [electronic resource] - Current pharmaceutical design 2014 - 6555-64 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1873-4286

10.2174/1381612820666140826153347 doi


Humans
Neoplasms--drug therapy
Signal Transduction--drug effects
Toll-Like Receptor 3--agonists